Overview

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The aim of this 20 week study is to show that glimepiride/atorvastatin fixed dose combination tablet is safe and as effective as atorvastatin + glimepiride combination taken as separate tablets, in improving glycaemic control (glycated haemoglobin, HbA1c) and cholesterol levels (Low-density lipoprotein, LDL) in diabetic subjects, who are inadequately controlled on a stable dose of metformin. Eight dose combinations will be included.

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Atorvastatin
Atorvastatin Calcium
Glimepiride